Delivery of quinolone antibacterials to turbot, Scophthalmus maximus (L.), via bioencapsulation: quantification and efficacy trial
- 1 May 1995
- journal article
- Published by Wiley in Journal of Fish Diseases
- Vol. 18 (3) , 229-238
- https://doi.org/10.1111/j.1365-2761.1995.tb00298.x
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- OPTIMIZED FEEDING REGIMES IN SHRIMP HATCHERIESPublished by Elsevier ,1992
- Live-food mediated drug delivery as a tool for disease treatment in larviculture. The enrichment of therapeutics in Rotifers and Artemia naupliiAquacultural Engineering, 1992
- Liquid chromatographic determination of efficacy of incorporation of trimethoprim and sulfamethoxazole in brine shrimp (Artemia spp.) used for prophylactic chemotherapy of fishAntimicrobial Agents and Chemotherapy, 1991
- The use of API 20E for the identification of Vibrio anguillarum and V. ordaliiJournal of Fish Diseases, 1991
- Bioencapsulation of Therapeutic Quantities of the Antibacterial Romet-30 in Nauplii of the Brine Shrimp Artemia and in the Nematode Panagrellus redivivusJournal of the World Aquaculture Society, 1990
- Fisheries Chemotherapy: A ReviewPublished by Springer Nature ,1988
- Survival and growth of turbot larvae Scophthalmus maximus L. Reared on different food organisms with special regard to long-chain polyunsaturated fatty acidsAquacultural Engineering, 1984
- A technical solution to the mass-culturing of larval turbotAquacultural Engineering, 1983